UBS O'Connor’s Cartesian Growth Corporation II Warrant RENEW Stock Holding History

UBS O'Connor’s Portfolio RENEW Stock Details RENEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-118,982	Closed	-$7.4K	–	445
2025 Q1	$7.4K	Hold	118,982	–	–	﹤0.01%	312
2024 Q4	$10.1K	Hold	118,982	–	–	﹤0.01%	396
2024 Q3	$7.75K	Sell	118,982 -3,844	-3%	-$314	﹤0.01%	470
2024 Q2	$13.7K	Hold	122,826	–	–	﹤0.01%	489
2024 Q1	$13.5K	Hold	122,826	–	–	﹤0.01%	475
2023 Q4	$16.6K	Buy	+122,826	New	+$15.8K	﹤0.01%	450

Other funds holding RENEW

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

UBS O'Connor's RENEW Position: Q2 2025 in Review

UBS O'Connor sold out of Cartesian Growth Corporation II Warrant (RENEW) in Q2 2025, closing a stake of 118,982 shares — an estimated $7.4K sold.

UBS O'Connor first reported a position in RENEW in Q4 2023 and held it in 6 quarters. The position peaked at $16.6K in Q4 2023. 2 funds tracked by Wall St. Rank hold RENEW as of Q2 2025.

UBS O'Connor reported no remaining Cartesian Growth Corporation II Warrant position as of Q2 2025 after selling out during the quarter.
UBS O'Connor sold 118,982 Cartesian Growth Corporation II Warrant shares in Q2 2025, an estimated $7.4K.
UBS O'Connor first reported a position in Cartesian Growth Corporation II Warrant in Q4 2023 and held it in 6 quarters.
UBS O'Connor's Cartesian Growth Corporation II Warrant position peaked at $16.6K in Q4 2023.
2 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Warrant as of Q2 2025.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.